Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Dow
Express Scripts
Harvard Business School
McKesson

Last Updated: February 7, 2023

ZILXI Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


When do Zilxi patents expire, and what generic alternatives are available?

Zilxi is a drug marketed by Journey and is included in one NDA. There are eight patents protecting this drug and one Paragraph IV challenge.

This drug has twenty-seven patent family members in ten countries.

The generic ingredient in ZILXI is minocycline hydrochloride. There are fifteen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the minocycline hydrochloride profile page.

Paragraph IV (Patent) Challenges for ZILXI
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
ZILXI Topical Aerosol Foam minocycline hydrochloride 1.50% 213690 1 2022-02-28

US Patents and Regulatory Information for ZILXI

ZILXI is protected by eight US patents.

Patents protecting ZILXI

Topical tetracycline compositions
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA.

Compositions, gels and foams with rheology modulators and uses thereof
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Topical tetracycline compositions
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA.

Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA.

Topical tetracycline compositions
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA.

Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Topical tetracycline compositions
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA.

Topical tetracycline compositions
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA.

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Journey ZILXI minocycline hydrochloride AEROSOL, FOAM;TOPICAL 213690-001 May 28, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Journey ZILXI minocycline hydrochloride AEROSOL, FOAM;TOPICAL 213690-001 May 28, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Journey ZILXI minocycline hydrochloride AEROSOL, FOAM;TOPICAL 213690-001 May 28, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Journey ZILXI minocycline hydrochloride AEROSOL, FOAM;TOPICAL 213690-001 May 28, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Journey ZILXI minocycline hydrochloride AEROSOL, FOAM;TOPICAL 213690-001 May 28, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Journey ZILXI minocycline hydrochloride AEROSOL, FOAM;TOPICAL 213690-001 May 28, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Journey ZILXI minocycline hydrochloride AEROSOL, FOAM;TOPICAL 213690-001 May 28, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for ZILXI

See the table below for patents covering ZILXI around the world.

Country Patent Number Title Estimated Expiration
World Intellectual Property Organization (WIPO) 2011039637 See Plans and Pricing
Mexico 359879 COMPOSICIONES TÓPICAS DE TETRACICLINA. (TOPICAL TETRACYCLINE COMPOSITIONS.) See Plans and Pricing
World Intellectual Property Organization (WIPO) 2013136192 See Plans and Pricing
Canada 2776471 COMPOSITIONS MOUSSANTES DEPOURVUES D'AGENT TENSIOACTIF ET D'EAU ET MOUSSES CASSABLES ET LEURS UTILISATIONS (SURFACTANT-FREE, WATER-FREE, FOAMABLE COMPOSITIONS AND BREAKABLE FOAMS AND THEIR USES) See Plans and Pricing
Brazil 112012007473 composições tópicas de tetraciclina e respectivo método de uso See Plans and Pricing
Canada 2776482 COMPOSITIONS, GELS ET MOUSSES COMPRENANT DES MODULATEURS DE RHEOLOGIE ET LEURS UTILISATIONS (COMPOSITIONS, GELS AND FOAMS WITH RHEOLOGY MODULATORS AND USES THEREOF) See Plans and Pricing
Australia 2015224534 SURFACTANT-FREE WATER-FREE FOAMABLE COMPOSITIONS, BREAKABLE FOAMS AND GELS AND THEIR USES See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Express Scripts
Moodys
Medtronic
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.